NDC 59267-0609

Pfizer-BioNTech Covid-19 Vaccine, Bivalent

Original And Omicron Ba.4/ba.5

Pfizer-BioNTech Covid-19 Vaccine, Bivalent is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Pfizer Manufacturing Belgium Nv. The primary component is Bnt162b2 Omicron (ba.4/ba.5); Tozinameran.

Product ID59267-0609_2e029bd9-2045-4cb3-9a39-011adb57d0b2
NDC59267-0609
Product TypeVaccine
Proprietary NamePfizer-BioNTech Covid-19 Vaccine, Bivalent
Generic NameOriginal And Omicron Ba.4/ba.5
Dosage FormInjection, Suspension
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2022-08-15
Marketing CategoryEMERGENCY USE AUTHORIZATION /
Labeler NamePfizer Manufacturing Belgium NV
Substance NameBNT162B2 OMICRON (BA.4/BA.5); TOZINAMERAN
Active Ingredient Strength0 mg/2.6mL; mg/2.6mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 59267-0609-2

10 VIAL, GLASS in 1 CARTON (59267-0609-2) > 2.6 mL in 1 VIAL, GLASS (59267-0609-1)
Marketing Start Date2022-08-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Pfizer-BioNTech Covid-19 Vaccine, Bivalent" or generic name "Original And Omicron Ba.4/ba.5"

NDCBrand NameGeneric Name
59267-0304Pfizer-BioNTech Covid-19 Vaccine, BivalentBNT162b2 Original and Omicron BA.4/BA.5
59267-0565Pfizer-BioNTech Covid-19 Vaccine, BivalentOriginal and Omicron BA.4/BA.5
59267-0609Pfizer-BioNTech Covid-19 Vaccine, BivalentOriginal and Omicron BA.4/BA.5
59267-1404Pfizer-BioNTech Covid-19 Vaccine, BivalentBNT162b2 Original and Omicron BA.4/BA.5

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.